dendritic cell
Sponsors
Medical University of South Carolina, Second Military Medical University, West China Second University Hospital, Stichting Leveronderzoek, Erasmus MC, Universitair Medisch Centrum Rotterdam
Conditions
Advanced Hepatocellular CarcinomaPancreatic Adenocarcinoma Non-resectableRecurrence Hepatocellular CarcinomaRecurrent Ovarian Cancerasbestos cancer
peritoneal mesentheliomapancreatic cancer
pancreatic ductal adenocarcinoma
Phase 1
A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma
CompletedNCT01677962
Start: 2012-08-31End: 2016-05-31Updated: 2016-12-15
Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma
NCT02638857
Start: 2015-09-30End: 2017-09-30Target: 60Updated: 2016-01-01
Dendritic Cell Vaccination With Standard Postoperative Chemotherapy for the Treatment of Adult Ovarian Cancer
NCT05270720
Start: 2022-09-01End: 2024-03-01Target: 9Updated: 2022-03-08
Phase 2
Autologous Dendritic Cells Loaded with Allogenic Tumor Lysate for Surgically Resected Pancreatic Cancer Patients (REACtiVe Trial)
NL-OMON45421
Target: 26Updated: 2024-02-28
Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma
Active, not recruitingNL-OMON48572
Start: 2018-03-28Target: 20Updated: 2024-02-28